- Home
- BZUN vs ME Comparison
BZUN vs ME Comparison
Compare BZUN & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- ME
- Stock Information
- Founded
- BZUN 2007
- ME 2006
- Country
- BZUN China
- ME United States
- Employees
- BZUN N/A
- ME N/A
- Industry
- BZUN Catalog/Specialty Distribution
- ME Precision Instruments
- Sector
- BZUN Consumer Discretionary
- ME Health Care
- Exchange
- BZUN Nasdaq
- ME Nasdaq
- Market Cap
- BZUN 188.7M
- ME 98.7M
- IPO Year
- BZUN N/A
- ME N/A
- Fundamental
- Price
- BZUN $2.74
- ME $3.39
- Analyst Decision
- BZUN Strong Buy
- ME Hold
- Analyst Count
- BZUN 3
- ME 1
- Target Price
- BZUN $3.20
- ME $9.40
- AVG Volume (30 Days)
- BZUN 874.6K
- ME 219.4K
- Earning Date
- BZUN 11-21-2024
- ME 02-05-2025
- Dividend Yield
- BZUN N/A
- ME N/A
- EPS Growth
- BZUN N/A
- ME N/A
- EPS
- BZUN N/A
- ME N/A
- Revenue
- BZUN $1,312,737,613.00
- ME $193,260,000.00
- Revenue This Year
- BZUN $8.16
- ME $21.93
- Revenue Next Year
- BZUN $4.71
- ME $17.31
- P/E Ratio
- BZUN N/A
- ME N/A
- Revenue Growth
- BZUN 7.26
- ME N/A
- 52 Week Low
- BZUN $1.90
- ME $2.66
- 52 Week High
- BZUN $4.38
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- BZUN 46.21
- ME 44.56
- Support Level
- BZUN $2.67
- ME $3.15
- Resistance Level
- BZUN $3.09
- ME $4.18
- Average True Range (ATR)
- BZUN 0.17
- ME 0.26
- MACD
- BZUN -0.03
- ME 0.05
- Stochastic Oscillator
- BZUN 14.08
- ME 29.46
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.